Abstracts

INCREASED GENITAL INFLAMMATION IN WOMEN RANDOMIZED TO COPPER IUD IN THE ECHO TRIAL

The inflammatory milieu of the lower female genital tract contributes substantially to HIV acquisition risk. In the randomized ECHO trial, we investigated whether the intramuscular injectable depo-medroxyprogesterone acetate (DMPA-IM) influenced genital inflammation, relative to the levonorgestrel implant (LNG-Implant) and non-hormonal copper intrauterine device (Copper-IUD). Cervicovaginal secretions (CVS) were collected via menstrual cups at three sites…

CONTRACEPTIVE USE INDUCES DURABLE SHIFTS IN THE FEMALE GENITAL-TRACT MICROBIOTA

Vaginal bacterial microbiota modulate genital immunity and susceptibility to HIV and other sexually transmitted pathogens. However, it is unclear how contraceptive use affects the composition and dynamics of these communities. Within the ECHO trial, designed to compare the relative HIV-1 incidence among women randomized to copper intrauterine device (Cu-IUD), levonorgesterol implant (LNG-implant), or DMPA-IM, this…

A COMBINED ESTROGEN/PROGESTIN VAGINAL RING IMPROVES VAGINAL MICROBIAL COMMUNITIES

ACTG study A5316 found that during contraceptive intravaginal ring (IVR) use over 3 weeks, efavirenz-based ART (EFV) significantly decreased both ethinyl estradiol (EE) and etonogestrel (ENG) plasma exposure, while atazanavir/ritonavir-based ART (ATV) decreased EE, yet increased ENG. We explored the role of the IVR on vaginal microbial communities and vaginal small chain fatty acids (SCFA)…

NO EVIDENCE OF CLINICAL IMPACT OF STIs ON SEMINAL HIV BURDEN DURING SUCCESSFUL ART

Sexually transmitted infections (STI) are known to increase the HIV shedding in semen of ART naïve patients. Their role in influencing the seminal compartment despite peripheral undetectable HIV-RNA is still unclear. This ongoing study includes 25 HIV-1 patients (pts) with undetectable viremia (<20cps/ml) for at least 1year. At enrolment, 10 were STI-positive (cases:7syphilis, 1M.genitalium, 1U.urealyticum…

VALIDATING INCIDENT PREGNANCIES AMONG WOMEN USING CONTRACEPTIVES AND ANTIRETROVIRALS

A prior cohort study from Kenya demonstrated reduced effectiveness of contraceptive implants when used in combination with efavirenz-containing antiretroviral therapy (ART). To further validate this finding, we conducted two-phase random sampling with an expanded cohort of women living with HIV (WLHIV) using data from the East Africa International Epidemiology Databases to Evaluate AIDS. We conducted…